Age
(years) |
Male |
Female |
Total |
|||
Number |
% |
Number |
% |
Number |
% |
|
0-14 |
2 |
0.17 |
4 |
0.34 |
6 |
0.50 |
15-34 |
63 |
5.32 |
68 |
5.73 |
131 |
11.05 |
35-64 |
300 |
25.30 |
383 |
32.29 |
683 |
57.59 |
65+ |
231 |
19.48 |
135 |
11.38 |
366 |
30.86 |
Total |
596 |
50.25 |
590 |
49.75 |
1186 |
100.00 |
Sr.
No. |
Characteristic |
Number |
Percentage |
|
1 |
Religion |
Hindus |
1136 |
95.78 |
Muslims |
50 |
4.22 |
||
Total |
1186 |
100.00 |
||
2 |
Residence |
Urban |
389 |
32.80 |
Rural |
797 |
67.20 |
||
Total |
1186 |
100.00 |
||
3 |
Socio-economic status |
APL |
351 |
29.60 |
BPL |
835 |
70.40 |
||
Total |
1186 |
100.00 |
||
4 |
Dietary habits |
Vegetarians |
900 |
75.89 |
Non-vegetarians |
286 |
24.11 |
||
Total |
1186 |
100.00 |
||
5 |
Addiction |
Tobacco alone |
308 |
25.97 |
Alcohol Alone |
18 |
1.52 |
||
Tobacco + Alcohol |
221 |
18.63 |
||
No addiction |
639 |
53.88 |
||
Total |
1186 |
100.00 |
Males |
Females |
||||
Site |
No. |
Percentage |
Site |
No. |
Percentage |
Colorectal |
67 |
11.24 |
Breast |
219 |
37.12 |
Prostate |
61 |
10.24 |
Gall Bladder |
76 |
12.88 |
Penis |
61 |
10.24 |
Colorectal |
43 |
7.28 |
Gall Bladder |
49 |
8.22 |
Cervix |
39 |
6.61 |
Stomach |
45 |
7.55 |
Stomach |
33 |
5.59 |
Skin+Soft tissue |
42 |
7.05 |
Cholangiocarcinoma |
24 |
4.06 |
Periampullary |
41 |
6.88 |
Skin+Soft tissue |
22 |
3.73 |
Oral cavity |
41 |
6.88 |
Periampullary |
19 |
3.22 |
Hepatocellular |
27 |
4.53 |
Hepatocellular |
19 |
3.22 |
Urinary Bladder |
24 |
4.03 |
Ovary |
19 |
3.22 |
10 commonest |
458 |
76.84 |
10 commonest |
513 |
86.94 |
Others |
138 |
23.16 |
Others |
77 |
13.06 |
Total |
596 |
100.00 |
Total |
590 |
100.00 |
Pediatric |
Young
adult |
Middle |
Geriatric |
||||||||
Site |
No. |
% |
Site |
No. |
% |
Site |
No. |
% |
Site |
No. |
% |
Kidney |
4 |
66.66 |
Colorectal |
19 |
14.51 |
Breast |
170 |
24.89 |
Gall Bladder |
51 |
13.93 |
Colorectal |
1 |
16.67 |
Breast |
18 |
13.74 |
Gall Bladder |
64 |
9.37 |
Prostate |
45 |
12.31 |
Retroperitoneal |
1 |
16.67 |
Skin |
14 |
10.69 |
Colorectal |
56 |
8.20 |
Breast |
38 |
10.38 |
|
|
|
Testis |
11 |
8.40 |
Stomach |
42 |
6.15 |
Colorectal |
34 |
9.29 |
|
|
|
Gall Bladder |
10 |
7.63 |
Periampullary |
41 |
6.00 |
Stomach |
32 |
8.74 |
|
|
|
CNS |
8 |
6.11 |
Penis |
33 |
4.83 |
Penis |
26 |
7.10 |
|
|
|
Hepatocellular |
6 |
4.58 |
Cervix |
30 |
4.39 |
Skin |
21 |
5.74 |
|
|
|
Oral cavity |
6 |
4.58 |
Oral cavity |
30 |
4.39 |
Urinary Bladder |
17 |
4.64 |
|
|
|
Bone |
4 |
3.05 |
Skin |
29 |
4.25 |
Periampullary |
16 |
4.37 |
|
|
|
Stomach |
4 |
3.05 |
Hepatocellular |
29 |
4.25 |
Esophagus |
16 |
4.37 |
|
|
|
Lymphoma |
4 |
3.05 |
|
|
|
|
|
|
|
|
|
Cervix |
4 |
3.05 |
|
|
|
|
|
|
10 Commonest |
6 |
100 |
10 commonest |
108 |
82.44 |
10 commonest |
524 |
76.72 |
10 commonest |
296 |
80.87 |
Others |
0 |
0 |
Others |
23 |
17.56 |
Others |
159 |
23.28 |
Others |
70 |
19.13 |
Total |
6 |
100 |
Total |
131 |
100 |
Total |
683 |
100 |
Total |
366 |
100 |
Site |
Total
no. of cases |
Presented
with metastasis |
Percentage |
Gall Bladder |
125 |
58 |
46.40% |
Cervix |
39 |
24 |
61.53% |
Liver 2ndaries,
Primary unknown |
21 |
21 |
100.00% |
Breast |
226 |
19 |
8.41% |
Colorectum |
110 |
17 |
15.45% |
Stomach |
78 |
10 |
12.82% |
Prostate |
61 |
8 |
13.11% |
Ovary |
19 |
8 |
42.10% |
Testis |
18 |
8 |
44.44% |
Hepatocellular Carcinoma |
46 |
8 |
17.39% |
10 commonest |
743 |
181 |
24.36% |
Others |
443 |
37 |
8.35% |
Total |
1186 |
218 |
18.38% |
Sl.
No. |
Age
(years) |
Number |
% |
|
1 |
0-14 |
0 |
0.00 |
|
15-34 |
10 |
10.99 |
||
35-64 |
49 |
53.85 |
||
65+ |
32 |
35.16 |
||
Total |
91 |
100.00 |
||
2 |
Gender |
Number |
% |
|
Male |
56 |
61.54 |
||
Female |
35 |
38.46 |
||
Total |
91 |
100.00 |
Site
of Cancer |
Total |
|
Number |
Percent |
|
Gall Bladder |
13 |
14.29 |
Colorectum |
12 |
13.17 |
Stomach |
9 |
9.88 |
Hepatocellular Carcinoma |
7 |
7.68 |
CNS (Brain+spinal
cord) |
5 |
5.49 |
Periampullary |
5 |
5.49 |
Esophagus |
4 |
4.40 |
Prostate |
4 |
4.40 |
Oral cavity |
4 |
4.40 |
Skin+soft tissue |
4 |
4.40 |
10 commonest |
67 |
73.60 |
Others |
24 |
26.40 |
Total |
91 |
100.00 |
Present
study |
In
India12 |
Globally7 |
|||||||||
Males |
Females |
Males |
Females |
Males |
Females |
||||||
Site |
% |
Site |
% |
Site |
% |
Site |
% |
Site |
% |
Site |
% |
Colorectal |
11.24 |
Breast |
37.12 |
Lungs |
11.3 |
Breast |
27.0 |
Lungs |
16.7 |
Breast |
25.2 |
Prostate |
10.24 |
Gall Bladder |
12.88 |
Oral |
11.3 |
Cervix |
22.9 |
Prostate |
15.0 |
Colorectal |
9.2 |
Penis |
10.24 |
Colorectal |
7.28 |
Stomach |
9.1 |
Colorectal |
5.1 |
Colorectal |
10.0 |
Lungs |
8.8 |
Gall Bladder |
8.22 |
Cervix |
6.61 |
Colorectal |
7.7 |
Ovary |
5.0 |
Stomach |
8.5 |
Cervix |
7.9 |
Stomach |
7.55 |
Stomach |
5.59 |
Pharynx |
6.6 |
Oral |
4.3 |
Liver |
7.5 |
Uterus |
4.8 |
Skin |
7.05 |
Cholangio |
4.06 |
Esophagus |
5.7 |
Stomach |
3.7 |
UrinaryBladder |
4.4 |
Stomach |
4.8 |
Periampullary |
6.88 |
Skin |
3.73 |
Larynx |
4.8 |
Lungs |
3.1 |
Esophagus |
4.3 |
Ovary |
3.6 |
Oral cavity |
6.88 |
Periampullary |
3.22 |
Leukaemia |
4.1 |
Esophagus |
2.7 |
Kidney |
2.9 |
Thyroid |
3.5 |
Hepatocellular |
4.53 |
Hepatocellular |
3.22 |
Prostate |
4.0 |
Leukaemia |
2.4 |
NHL |
2.9 |
Liver |
3.4 |
UrinaryBladder |
4.03 |
Ovary |
3.22 |
Liver |
3.6 |
Uterus |
2.3 |
Leukaemias |
2.7 |
NHL |
2.5 |
Present
study |
In
India12 |
Globally7 |
|||||||||
Males |
Females |
Males |
Females |
Males |
Females |
||||||
Site |
% |
Site |
% |
Site |
% |
Site |
% |
Site |
% |
Site |
% |
Stomach |
12.49 |
Gall Bladder |
20.00 |
Lung |
13.7 |
Breast |
21.5 |
Lung |
23.6 |
Breast |
14.7 |
Gall Bladder |
10.70 |
Colorectal |
17.14 |
Stomach |
11.4 |
Cervix |
20.7 |
Liver |
11.2 |
Lung |
13.8 |
Colorectal |
10.70 |
Cervix |
8.57 |
Oral |
10.2 |
Colorectal |
6.4 |
Stomach |
10.1 |
Colorectal |
9.0 |
Prostate |
7.14 |
Thyroid |
8.57 |
Colorectal |
7.8 |
Ovary |
6.0 |
Colorectal |
8.0 |
Cervix |
7.5 |
Periampullary |
7.14 |
Hepatocellular |
8.57 |
Pharynx |
7.6 |
Stomach |
5.6 |
Prostate |
6.6 |
Stomach |
7.2 |
Hepatocellular |
7.14 |
Stomach |
5.71 |
Esophagus |
7.1 |
Oral |
4.8 |
Esophagus |
6.0 |
Liver |
6.3 |
Esophagus |
5.36 |
Oral |
5.71 |
Liver |
4.7 |
Lungs |
4.6 |
Leukemia |
3.3 |
Ovary |
4.3 |
CNS |
5.36 |
CNS |
5.71 |
Leukemia |
4.5 |
Esophagus |
4.1 |
Urinary Bladder |
2.6 |
NHL |
2.4 |
Skin |
5.36 |
Cholangio |
5.71 |
Larynx |
4.4 |
Leukemia |
3.3 |
NHL |
2.5 |
Uterus |
2.1 |
Hematological |
5.36 |
Periampullary |
2.86 |
Prostate |
3.4 |
Uterus |
1.5 |
Kidney |
2.0 |
Thyroid |
0.8 |